世界の美容医療機器市場は2031年までに11.1％の注目すべきCAGRを達成する見込みです。低侵襲および非侵襲再建手術の需要増大、機器および手術の大幅な改善などが市場の主な推進要因です。その他の重要な市場推進要因としては、先天性顔面および歯の奇形の発生数の増加、ならびに審美的外観に対する意識の高まりがあります。
目次
Contents
1. Executive Summary
2. Global Aesthetic Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Aesthetic Devices Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Aesthetic Devices Market
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. Global Aesthetic Devices Market: Market Segmentation
12.1. By Regions
12.1.1. North America:( United States, Mexico, and Canada), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Latin America: (Columbia, Brazil, and Rest of Latin America), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Europe: (United Kingdom, France, Germany, Italy, Spain, and Rest of Europe), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Asia-Pacific: (India, China, South Korea, Japan, Australia, and Rest of Asia Pacific), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.5. The Middle East and Africa: (Saudi Arabia, and Rest of the Middle East and Africa), By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Product: Market Share (2020-2031F)
12.2.1. Devices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Aesthetic Implants, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Application: Market Share (2020-2031F)
12.3.1. Surgical, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Non-Surgical, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End-Use Product Type: Market Share (2020-2031F)
12.4.1. Hospitals and Clinics, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Medical Spas and Beauty Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. Company Profile
13.1. Allergan plc
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Dentsply Sirona Inc.
13.3. Johnson & Johnson
13.4. Lumenis Ltd
13.5. Merz Pharma Gmbh & Co. Kgaa
13.6. Hologic, Inc.
13.7. Sientra Inc
13.8. Syneron Medical Ltd
13.9. Valeant Pharmaceutical International, Inc
13.10. Zimmer Biomet Holdings, Inc.
13.11. Other Prominent Players
Consultant Recommendation
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
